$6.87
-0.23 (-3.24%)
Orexigen Therapeutics, Inc. (OREX)
CAPS Rating:
A biopharmaceutical company focused on the development of pharmaceutical product candidates for the treatment of central nervous system, disorders, with an initial focus on obesity.

RSS Headlines
Fool UK